Literature DB >> 28515152

Effects of deficiency of Kelch-like ECH-associated protein 1 on skeletal organization: a mechanism for diminished nuclear factor of activated T cells cytoplasmic 1 during osteoclastogenesis.

Eiko Sakai1, Masanobu Morita2,3, Masahiro Ohuchi4, Mizuho A Kido5, Yutaka Fukuma6, Kazuhisa Nishishita6, Kuniaki Okamoto6, Ken Itoh7, Masayuki Yamamoto2, Takayuki Tsukuba6.   

Abstract

Kelch-like ECH-associated protein 1 (Keap1) binds to nuclear factor E2 p45-related factor 2 (Nrf2), a transcription factor for antioxidant enzymes, to suppress Nrf2 activation. The role of oxidative stress in many diseases supports the possibility that processes that are associated with Nrf2 activation might offer therapeutic potential. Nrf2 deficiency induces osteoclastogenesis, which is responsible for bone loss, by activating receptor activator of NF-κB ligand (RANKL)-mediated signaling; however, the effects of Keap1 deficiency remain unclear. By using Keap1-deficient newborn mice, we observed that talus and calcaneus bone formation was partially retarded and that osteoclast number was reduced in vivo without severe gross abnormalities. In addition, Keap1-deficient macrophages were unable to differentiate into osteoclasts in vitrovia attenuation of RANKL-mediated signaling and expression of nuclear factor of activated T cells cytoplasmic 1 (NFATc1), a key transcription factor that is involved in osteoclastogenesis. Furthermore, Keap1 deficiency up-regulated the expression of Mafb, a negative regulator of NFATc1. RANKL-induced mitochondrial gene expression is required for down-regulation of IFN regulatory factor 8 (IRF-8), a negative transcriptional regulator of NFATc1. Our results indicate that Keap1 deficiency down-regulated peroxisome proliferator-activated receptor-γ coactivator 1β and mitochondrial gene expression and up-regulated Irf8 expression. These results suggest that the Keap1/Nrf2 axis plays a critical role in NFATc1 expression and osteoclastogenic progression.-Sakai, E., Morita, M., Ohuchi, M., Kido, M. A., Fukuma, Y., Nishishita, K., Okamoto, K., Itoh, K., Yamamoto, M., Tsukuba, T. Effects of deficiency of Kelch-like ECH-associated protein 1 on skeletal organization: a mechanism for diminished nuclear factor of activated T cells cytoplasmic 1 during osteoclastogenesis. © FASEB.

Entities:  

Keywords:  Blimp1; IRF-8; MafB; Nrf2; oxidative stress

Mesh:

Substances:

Year:  2017        PMID: 28515152     DOI: 10.1096/fj.201700177R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  6 in total

1.  Cancer Stem Cells: Emergent Nature of Tumor Emergency.

Authors:  Yaroslav R Efremov; Anastasia S Proskurina; Ekaterina A Potter; Evgenia V Dolgova; Oksana V Efremova; Oleg S Taranov; Aleksandr A Ostanin; Elena R Chernykh; Nikolay A Kolchanov; Sergey S Bogachev
Journal:  Front Genet       Date:  2018-11-16       Impact factor: 4.599

2.  Liquid-phase ASEM imaging of cellular and structural details in cartilage and bone formed during endochondral ossification: Keap1-deficient osteomalacia.

Authors:  Eiko Sakai; Mari Sato; Nassirhadjy Memtily; Takayuki Tsukuba; Chikara Sato
Journal:  Sci Rep       Date:  2021-03-11       Impact factor: 4.379

Review 3.  The Role of NRF2 in Bone Metabolism - Friend or Foe?

Authors:  Jie Han; Kuan Yang; Jinyang An; Na Jiang; Songbo Fu; Xulei Tang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-23       Impact factor: 5.555

4.  Moderate Nrf2 Activation by Genetic Disruption of Keap1 Has Sex-Specific Effects on Bone Mass in Mice.

Authors:  Yukun Yin; Kylie A Corry; John P Loughran; Jiliang Li
Journal:  Sci Rep       Date:  2020-01-15       Impact factor: 4.379

5.  NRF2 Is an Upstream Regulator of MYC-Mediated Osteoclastogenesis and Pathological Bone Erosion.

Authors:  Peter Sang Uk Park; Se Hwan Mun; Steven L Zeng; Haemin Kim; Seyeon Bae; Kyung-Hyun Park-Min
Journal:  Cells       Date:  2020-09-21       Impact factor: 6.600

Review 6.  PERK signaling pathway in bone metabolism: Friend or foe?

Authors:  Jiachao Guo; Ranyue Ren; Kai Sun; Jinpeng He; Jingfan Shao
Journal:  Cell Prolif       Date:  2021-02-21       Impact factor: 6.831

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.